Symptoms
Since abnormal cervical cell changes rarely
cause symptoms, it is important to have regular
Pap test
screening. If cervical cell changes progress
to
cervical cancer
, symptoms may develop. Symptoms of
cervical cancer may include:
- Abnormal vaginal bleeding or a significant
unexplained change in your
menstrual cycle
.
- Bleeding when something
comes in contact with the cervix, such as during sexual intercourse or when you
insert a diaphragm.
- Pain during sexual
intercourse.
- Abnormal vaginal discharge containing mucus that may
be tinged with blood.
Symptoms that may occur when your cervical cancer has
progressed include:
-
Anemia
because
of abnormal vaginal bleeding.
- Ongoing pelvic, leg, or back
pain.
- Urinary problems because of blockage of a kidney or
ureter
.
- Leakage of urine or fecal content
into the
vagina
because an abnormal opening (
fistula
) has developed between the vagina and the
bladder or rectum.
- Weight loss.
Guintoli RL II, Bristow RE (2008). Cervical cancer. In
RS Gibbs et al., eds., Danforth's Obstetrics and Gynecology, 10th ed., pp. 971–988. Philadelphia: Lippincott Williams and
Wilkins.
Cannistra SA (2007). Gynecologic cancer. In DC Dale,
DD Federman, eds., ACP Medicine, section 12, chap. 10.
New York: WebMD.
Eifel PJ, et al. (2004). Pelvic irradiation with
concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk
cervical cancer: An update of Radiation Therapy Oncology Group Trial (RTOG)
90-01. Journal of Clinical Oncology, 22(5):
872–880.
Trimble CL, et al. (2005). Active and passive
cigarette smoking and the risk of cervical neoplasia. Obstetrics and Gynecology, 105(1): 174–181.
Moreno V, et al. (2002). Effect of oral contraceptives
on risk of cervical cancer in women with human papillomavirus infection: The
IARC muticentric case-control study. Lancet, 359(9312):
1085–1092.
Chirenje ZM (2005). HIV and cancer of the cervix. Best Practice and Research Clinical Obstetrics and Gynaecology, 19(2): 269–276.
Waggoner SE (2003). Cervical cancer. Lancet, 361: 2217–2225.
Thigpen T (2003). The role of chemotherapy in the
management of carcinoma of the cervix. Cancer Journal,
9(5): 425–432.
Sundar S, et al. (2008). Cervical cancer, search date
November 2006. Online version of BMJ Clinical Evidence.
Also available online: http://www.clinicalevidence.com.
Janicek MF, Averette HE. (2001). Cervical cancer:
Prevention, diagnosis, and therapeutics. CA, A Cancer Journal for Clinicians, 51: 92–114.
Holschneider CH (2007). Premalignant and malignant
disorders of the uterine cervix. In AH DeCherney et al., eds., Current Diagnosis and Treatment Obstetrics and Gynecology,
10th ed., pp. 833–854. New York: McGraw-Hill Medical Publishing
Division.
American College of Obstetricians and Gynecologists
(2002, reaffirmed 2006). Diagnosis and treatment of cervical carcinomas. ACOG
Practice Bulletin No. 35. Obstetrics and Gynecology,
99(5): 855–867.
National Cancer Institute (2008). Cervical Cancer (PDQ): Prevention—Health Professional Version.
Available online:
http://www.nci.nih.gov/cancertopics/pdq/prevention/cervical/healthprofessional.
U.S. Food and Drug Administration (2006). FDA licenses new vaccine for prevention of cervical cancer and other diseases in females caused by human papillomavirus. FDA News. Available online: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01385.html.
Winer RL, et al. (2006). Condom use and the risk of genital human papillomavirus infection in young women. New England Journal of Medicine, 354(25): 2645–2654.
Lertsanguansinchai P, et al. (2004). Phase III
randomized trial comparing LDR and HDR brachytherapy in treatment of cervical
carcinoma. International Journal of Radiation Oncology Biology Physics, 59(5): 1424–1431.
Baxter NN, et al. (2005). Risk of pelvic fractures in older women following pelvic irradiation. JAMA, 294(20): 2587–2593.
